acetohydroxamic acid has been researched along with 2-[(4-chlorophenyl)methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JY; Fields, GB; Hart, PJ; Hodder, PS; Jiang, J; Minond, D; Roush, WR; Spicer, TP; Taylor, AB | 1 |
1 other study(ies) available for acetohydroxamic acid and 2-[(4-chlorophenyl)methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one
| Article | Year |
|---|---|
Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.
Topics: Animals; Binding Sites; Cartilage; Cartilage, Articular; Cattle; Chemistry, Pharmaceutical; Collagen; Collagenases; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Drug Design; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Mice; Microsomes; Molecular Conformation; Osteoarthritis; Protein Binding; Protein Conformation; Rats; Structure-Activity Relationship | 2014 |